Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines
Synergistic effects of androgen and estrogen on the mouse uterus and mammary gland
Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors
Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells
Regulation of GCDFP-15 expression in human mammary cancer cells.